Cellebrite DI (CLBT) Invested Capital (2021 - 2026)

Cellebrite DI has reported Invested Capital for 6 years, with the latest figure at $562.7 million in Q2 2026.

• On a quarterly basis, Invested Capital rose 35.5% year-over-year to $562.7 million in Q2 2026; TTM through Jun 2026 was $562.7 million, a 35.5% increase from a year earlier, with the FY2025 full-year figure at $501.2 million, up 46.13% from the prior year.
• Invested Capital was $562.7 million for Q2 2026 at Cellebrite DI, up from $501.2 million in the prior quarter.
• The five-year high for Invested Capital was $562.7 million in Q2 2026, with the low at -$33.7 million in Q2 2024.
• Average Invested Capital over 5 years is $223.9 million, with a median of $93.8 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Invested Capital sank 248.95% in 2024, then jumped 1333.45% in 2025.
• Over 5 years, Invested Capital stood at $79.3 million in 2022, then climbed by 18.4% to $93.8 million in 2023, then surged by 265.47% to $343.0 million in 2024, then soared by 46.13% to $501.2 million in 2025, then climbed by 12.26% to $562.7 million in 2026.
• The last three Invested Capital figures came in at $562.7 million (Q2 2026), $501.2 million (Q4 2025), and $415.3 million (Q2 2025), per Business Quant data.